Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Iu D, Parfenov"'
Autor:
V M, Voronin, Iu D, Parfenov
Publikováno v:
Gigiena i sanitariia. (7)
Autor:
N Ia, Ianysheva, I A, Chernichenko, N V, Balenko, O N, Litvichenko, Iu D, Parfenov, M Iu, Antomonov, L T, Rusakova
Publikováno v:
Gigiena i sanitariia. (6)
Overt dependence of lung tumour development on the values of the dose administered was shown in experiments on inbred white rats under intratracheal administration of various doses of dibenz (a, h) anthracene (DBA); minimal-effect dose and maximal no
Publikováno v:
Gigiena i sanitariia. (4)
Maximum allowable 24-hour human intakes of NDMA and NDEA, calculated with the use of a log-normal model, a model of logit-transformations and methods of confidence intervals and probability estimations, are 0.15 micrograms/kg and 0.03 micrograms/kg r
Autor:
D M, Maksimovich, Iu D, Parfenov
Publikováno v:
Voprosy onkologii. 36(3)
Publikováno v:
Voprosy onkologii. 36(5)
The administration of estradiol propionate after the discontinuation of 1,2-dimethylhydrazine (DMH) treatment increased the incidence of uterine sarcoma in CBA mice from 32.5 (DMH alone) to 62.5%. The addition of the ascorbic acid (0.3% solution in d
Publikováno v:
Eksperimental'naia onkologiia. 12(3)
The results of experiments on the 1,2-dimethylhydrazine (DMH) induction of epithelial renal tumours in CBA male mice are presented. The dose-response study shows a sharp increase (from 5 to 75%) of the epithelial renal tumour incidence in the range o
Autor:
V S, Turusov, Iu D, Parfenov
Publikováno v:
Voprosy onkologii. 30(9)
Publikováno v:
Voprosy onkologii. 35(1)
The study was concerned with the influence of single dose of estradiol dipropionate on its promoting effect on 1,2-dimethylhydrazine-induced tumors in female CBA/CaLac mice. Estradiol dipropionate given within 19 weeks did not affect carcinogenesis w
Publikováno v:
Radiobiologiia. 20(2)
Autor:
O V, Morozova, Iu D, Parfenov
Publikováno v:
Eksperimental'naia onkologiia. 8(3)
Uterine sarcomas in (CBA X C57B1)F1 mice receiving 1,2-dimethylhydrazine (DMH) developed in 20% of animals. Concomitant administration of estradiol-dipropionate (EP) in doses of 2, 10 and 30 micrograms/mouse significantly increased tumour incidence u